3Nicholas RS, Falvey H, Lemonas P, et al. Patient-relat- ed keloid scar assessment and outcome measures [J]. Plast Reconstr Surg, 2012, 129(3): 648-656.
4Lee Y, Baron ED. Photodynamic therapy: current evi- dence and applications in dermatology[J]. Semin Cutan Med Surg, 2011, 30(4): 199-209.
5Kloeters O, Tandara A, Mustoe TA. Hypertrophic scar model in the rabbit ear: a reproducible model for studying scar tissue behavior with new observations on silicone gel sheeting for scar reduction[J]. Wound Repair Regen, 2007, 15 Suppl 1:S40-5.
6Blazic TM, Brajac I. Defective induction of senescence during wound healing is a possible mechanism of keloid formation[J]. Med Hypotheses, 2006, 66(3): 649-652.
7Wang Q, Peng Z, Xiao S, et al. RNAi-mediated inhibi- tion of COL1A1 and COL3A1 in human skin fibroblasts [J]. ExpDermatol, 2007, 16(7): 611-617.
8Ulrich D, Ulrich F, Unglaub F, et al. Matrix metallo proteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids[J]. J Plast Reconstr Aesthet Surg, 2010, 63(6) : 1015-1021.
9Yeh FL, Shen HD, Tai HY. Decreased production of MCP-1 and MMP-2 by keloid-derived fibroblasts [J]. Burns, 2009, 35(3): 348-351.
